Sunshine Biopharma Inc. Quarterly Operating Income (Loss) in USD from Q1 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sunshine Biopharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q4 2024.
  • Sunshine Biopharma Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$2.09M, a 79.4% decline year-over-year.
  • Sunshine Biopharma Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$5.81M, a 21.5% decline year-over-year.
  • Sunshine Biopharma Inc. annual Operating Income (Loss) for 2024 was -$5.81M, a 21.5% decline from 2023.
  • Sunshine Biopharma Inc. annual Operating Income (Loss) for 2023 was -$4.79M, a 82.3% increase from 2022.
  • Sunshine Biopharma Inc. annual Operating Income (Loss) for 2022 was -$27M, a 1007% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$5.81M -$2.09M -$924K -79.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-01
Q3 2024 -$4.89M -$1.11M -$327K -41.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$4.56M -$1.27M -$254K -25.1% Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-08-20
Q1 2024 -$4.31M -$1.35M +$478K +26.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$4.79M -$1.16M +$22.2M +95% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-01
Q3 2023 -$27M -$779K +$939K +54.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$27.9M -$1.01M -$318K -45.7% Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-08-20
Q1 2023 -$27.6M -$1.83M -$606K -49.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$27M -$23.4M -$23.1M -8255% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$3.92M -$1.72M -$1.22M -246% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$2.7M -$696K -$307K -79.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$2.39M -$1.22M +$52.3K +4.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$2.44M -$280K +$63.7K +18.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-04
Q3 2021 -$2.5M -$496K -$429K -638% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$2.07M -$389K -$260K -202% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$1.81M -$1.28M -$1.24M -3284% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$577K -$343K -$92.7K -37% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$484K -$67.3K +$135K +66.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$619K -$129K -$62.4K -94.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$557K -$37.7K +$84.5K +69.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$642K -$251K -$122K -95.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$519K -$203K +$86.2K +29.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$605K -$66.2K +$514K +88.6% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-31
Q1 2019 -$1.12M -$122K +$44.5K +26.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 -$1.16M -$128K +$33.9K +20.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-01
Q3 2018 -$1.2M -$289K -$175K -154% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$1.02M -$581K -$108K -22.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 -$915K -$167K -$57.7K -52.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$857K -$162K +$174K +51.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-12
Q3 2017 -$1.03M -$114K +$2.21K +1.91% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$1.03M -$472K -$905 -0.19% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-17
Q1 2017 -$1.03M -$109K -$39.3K -56.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-22
Q4 2016 -$993K -$336K -$162K -92.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$831K -$116K -$2.96K -2.62% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-15
Q2 2016 -$828K -$471K -$103K -28% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$725K -$69.7K +$55.1K +44.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$780K -$174K +$132K +43.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 -$912K -$113K +$164K +59.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$1.08M -$368K +$397K +51.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-16
Q1 2015 -$1.47M -$125K +$281K +69.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$1.76M -$306K +$377K +55.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$2.13M -$277K -$99.7K -56.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$2.03M -$766K -$613K -402% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$1.42M -$406K +$517K +56% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$1.94M -$683K -$495K -263% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 -$1.44M -$178K +$199K +52.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$1.64M -$153K -$49.9K -48.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$1.59M -$923K -$884K -2247% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$707K -$188K +$186K +49.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-19
Q3 2012 -$892K -$376K -$260K -223% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-08
Q2 2012 -$633K -$103K -$86.2K -523% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-08
Q1 2012 -$546K -$39.3K +$9.89K +20.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$556K -$374K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$116K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$16.5K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 -$49.2K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.